Download Gentamicin Dosing And Therapeutic Drug Monitoring Guideline

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Neuropharmacology wikipedia , lookup

Drug design wikipedia , lookup

Drug interaction wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Drug discovery wikipedia , lookup

Medication wikipedia , lookup

Prescription costs wikipedia , lookup

Adherence (medicine) wikipedia , lookup

Electronic prescribing wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Bad Pharma wikipedia , lookup

Ofloxacin wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Dydrogesterone wikipedia , lookup

Hormesis wikipedia , lookup

Theralizumab wikipedia , lookup

Bilastine wikipedia , lookup

Transcript
Appendix 1. Clinical Guideline for Gentamicin Prescribing and Therapeutic Drug
Monitoring.
Click here for the full guideline
Patient >65 years old
OR eGFR <60
Ensure gentamcin levels
were taken at the correct
time.
<1mg/L
>1mg/L
Patient <65 years old
AND eGFR >60
Ensure gentamicin levels were taken
at the correct time
<1mg/L
>1mg/L BUT
>2mg/L
<2mg/L
Repeat the
dose
WITHOLD
Repeat
trough
levels until
cleared.
Reduce
dose and
repeat
Recheck
levels
every 3-4
days
Continue
therapy
Reduce dose but
give at the next
scheduled time.
Re-check levels
prior to the next
dose.
This level should
be <1mg/L
Recheck levels
every 3-4 days
Gentamicin Prescribing and Therapeutic Drug Monitoring
Page 1 of 4
WITHOLD
Dose will
need
reducing,
speak to
senior
colleague,
pharmacy or
microbiology
The Guidance
For indications refer to Trust antimicrobial guidelines on Trust intranet
or Microguide app on mobile devices
Gentamicin should be used as a single daily dose regime except for
the treatment of bacterial endocarditis.
Gentamicin has a potentially toxic side effect profile (nephrotoxicity
and ototoxicity.
Gentamicin should be used with caution in any patients with an
impaired renal function. Due to a reduced rate of drug clearance and
the potential for accumulation, this group of patients is particularly
susceptible to the adverse effects of gentamicin therapy.
Renal function should be determined using eGFR.
When prescribing gentamicin be aware of the other risk factors for AKI
These guidelines do not cover all scenarios e.g. If a patient’s creatinine
deteriorates during their illness (e.g. after the first dose or other doses
of gentamicin) - it will be difficult to determine whether this is related to
the systemic illness, or gentamicin toxicity, and it will also be difficult to
determine whether the patient will benefit more from further gentamicin
(to treat infection) or would benefit more from protecting renal function
(and hence using an alternative antibiotic from that point onwards).
Hence clinical decision making with advice from senior medical
colleagues (including microbiology consultants if necessary) is
recommended. The severity of the acute kidney injury will need to be
taken into account.
Gentamicin Prescribing and Therapeutic Drug Monitoring
Page 2 of 4
Monitoring
Target trough levels are <1mg/L and should be taken 0 to 6 hours prior
to next anticipated dose (i.e. 20-24 hours after the previous dose).
Patients under 65 years of age with an eGFR >60mls/min should be
given the second dose of gentamicin at the scheduled time regardless
of whether the level has been reported.
For patients undergoing renal replacement, those over 65 years of age
or with an eGFR of less than 60ml/min, subsequent doses should be
withheld until the trough level has been reported and is <1mg/L.
See below for level monitoring algorithm.
Timings of doses and administration.
The first dose of gentamicin must be given as soon as possible and
therefore at any time of day.
To facilitate future gentamicin trough level taking (if indicated) the
second dose may be given 20 to 36 hours after the first dose provided
the first gentamicin trough level is within the recommended range.
Dosing Information
Height
Age <65 years and
eGFR >60mls/min
Age >65 years or
eGRF<60mls/min
Dose 5mg/kg
Male
Female
Dose 3mg/kg
Male
Female
Feet
and
inches
5’
Centimetres
152.40
240mg
240mg
160mg
160mg
5’1”
154.94
240mg
240mg
160mg
160mg
5’2”
157.48
240mg
240mg
160mg
160mg
5’3”
160.02
320mg
240mg
160mg
160mg
5’4”
162.56
320mg
320mg
160mg
160mg
Gentamicin Prescribing and Therapeutic Drug Monitoring
Page 3 of 4
5’5”
165.10
320mg
320mg
240mg
160mg
5’6”
167.64
320mg
320mg
240mg
160mg
5’7”
170.18
320mg
320mg
240mg
240mg
5’8”
172.72
360mg
320mg
240mg
240mg
5’9”
175.26
360mg
320mg
240mg
240mg
5’10”
177.80
360mg
360mg
240mg
240mg
5’11”
180.34
360mg
360mg
240mg
240mg
6’
182.88
360mg
360mg
240mg
240mg
6’1”
185.42
440mg
360mg
240mg
240mg
6’2”
187.96
440mg
440mg
240mg
240mg
6’3”
190.50
440mg
440mg
240mg
240mg
6’4”
193.04
440mg
440mg
240mg
240mg
6’5”
195.58
440mg
440mg
240mg
240mg
6’6”
198.12
440mg
440mg
320mg
240mg
6’7”
200.66
440mg
440mg
320mg
240mg
Gentamicin Prescribing and Therapeutic Drug Monitoring
Page 4 of 4